Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Serum Magnesium and Vascular Calcification
This update reports the completion of a clinical trial evaluating the relationship between serum magnesium levels and vascular calcification…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. [Phase 2]
Phase 2 clinical trial update examining four dosing regimens of PROCRIT (epoetin alfa) in patients with chronic kidney disease and anemia, p…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia. [Phase 2]
Phase 2 trial update examining alternate dosing by initiating every two weeks of epoetin alfa (Procrit) to treat anemia associated with kidn…
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: MMF After Pediatric Liver Transplantation [NA]
Clinical trial evaluating mycophenolate mofetil after pediatric liver transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT) [Phase 2]
This Phase 2 clinical trial update reports on maintenance therapy with PROCRIT (epoetin alfa) for anemia associated with chronic kidney dise…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Weight Loss Improves Renal Hemodynamics [Phase 4]
A Phase 4 clinical trial update shows that weight loss improves renal hemodynamics in individuals with obesity and metabolic syndrome, with …
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease. [Phase 4]
This Phase 4 dose-conversion study of epoetin alfa in subjects with anemia of chronic kidney disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa) [Phase 4]
A Phase 4 trial assessing disability in anemic elderly patients with kidney disease treated with Procrit (epoetin alfa) has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR) [Phase 4]
The Phase 4 CHOIR trial evaluating correction of hemoglobin in anemia due to renal insufficiency was terminated. This update provides the tr…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease [Phase 1]
Phase 1 trial to characterize the pharmacokinetic and pharmacodynamic profiles of epoetin alfa (PROCRIT) in anemic patients with chronic kid…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency [Phase 4]
Phase 4 trial evaluating early correction of anemia in patients with chronic kidney disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Prevention of Contrast-Induced Nephropathy [NA]
This entry notes the completed clinical trial evaluating prevention of contrast-induced nephropathy sponsored by the University of Alberta.
-
CLINICAL_TRIALS research · 2011-05-10Clinical Trial Update: Pulmonary Hypertension Prevention in Hemodialysis
Clinical trial update on preventing pulmonary hypertension in patients undergoing hemodialysis related to chronic kidney disease.
-
CLINICAL_TRIALS research · 2011-05-04Clinical Trial Update: Inspiratory Muscle Training in Patients With End Stage Renal Failure [Phase 4]
This clinical trial update concerns a Phase 4 study of inspiratory muscle training in patients with end-stage renal disease; the current sta…
-
CLINICAL_TRIALS research · 2011-05-02Clinical Trial Update: Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure [Phase 3]
A Phase 3 non-inferiority trial comparing Actparin to heparin sodium in patients with chronic kidney disease.
-
FDA approval · 2011-04-27FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: Phosphate Binding of Chitosan Chewing Gum in Patients With Chronic Kidney Disease (CKD) [EARLY_Phase 1]
This update summarizes the results of an early-phase Phase 1 study evaluating chitosan chewing gum as a phosphate binder in patients with ch…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD) [Phase 2]
Phase 2 long-term safety study of paricalcitol injections in chronic kidney disease patients on hemodialysis has completed and results were …
-
CLINICAL_TRIALS withdrawal · 2011-04-19Clinical Trial Update: Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia [Phase 2]
A Phase 2 trial evaluating subcutaneous rilonacept for non-dialysis-dependent chronic kidney disease with anemia was withdrawn.
-
CLINICAL_TRIALS research · 2011-04-18Clinical Trial Update: FFT, Inflammation, Lipid Metabolism, Blood Pressure and Organ Damage in Patients With Obesity, Chronic Kidney Disease (CKD).
An update on a study investigating inflammation, lipid metabolism, blood pressure and organ damage in people with obesity and chronic kidney…
-
CLINICAL_TRIALS research · 2011-04-18Clinical Trial Update: The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) Patients [NA]
This entry notes a clinical trial update evaluating whether systemic dietary instruction can help manage plasma phosphorus levels in periton…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients [Phase 3]
Phase 3 trial results evaluating extended dosing of PROCRIT (epoetin alfa) for maintaining hemoglobin in pre-dialysis chronic kidney disease…
-
FDA label_change · 2011-04-06FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for ZEMPLAR (paricalcitol) from AbbVie, updating its labeling.
-
FDA approval · 2011-04-06FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Zemplar (paricalcitol) filed by AbbVie Inc., approving an update to the product labeling.
-
CLINICAL_TRIALS trial_result · 2011-04-04Clinical Trial Update: Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease [Phase 4]
This Phase 4 trial evaluates how different clopidogrel doses influence platelet inhibition in patients with chronic kidney disease and stabl…